Characterization of Mutational Status, Spheroid Formation, and Drug Response of a New Genomically-Stable Human Ovarian Clear Cell Carcinoma Cell Line, 105C.

Kolendowski, Bart; Valdes, Yudith Ramos; Hirte, Hal; Itamochi, Hiroaki; Lee, Wonjae; Carey, Mark; Shepherd, Trevor G; DiMattia, Gabriel E

Kolendowski, Bart; Valdes, Yudith Ramos; Hirte, Hal; Itamochi, Hiroaki; Lee, Wonjae; Carey, Mark; Shepherd, Trevor G; DiMattia, Gabriel E.

Affiliation

Kolendowski B; Mary & John Knight Translational Ovarian Cancer Research Unit, London Regional Cancer Program, London, ON N6A 5W9, Canada.
Valdes YR; Lawson Health Research Institute, London, ON N6C 2R5, Canada.
Hirte H; Mary & John Knight Translational Ovarian Cancer Research Unit, London Regional Cancer Program, London, ON N6A 5W9, Canada.
Itamochi H; Lawson Health Research Institute, London, ON N6C 2R5, Canada.
Lee W; Juravinski Cancer Centre, Hamilton, ON L8V 5C2, Canada.
Carey M; Department of Obstetrics and Gynecology, Tottori University School of Medicine, Nishi-cho, Yonago-shi, Tottori-ken 683-0826, Japan.
Shepherd TG; Mary & John Knight Translational Ovarian Cancer Research Unit, London Regional Cancer Program, London, ON N6A 5W9, Canada.
DiMattia GE; Lawson Health Research Institute, London, ON N6C 2R5, Canada.

Cells ; 9(11)2020 11 03.

Article de En | MEDLINE | ID: mdl-33153119

Sujet(s)
Mots clés

OCCC; cancer; cell line; clear cell; epithelial ovarian cancer; mTOR inhibitor; ovarian; spheroid

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'ovaire / Sphéroïdes de cellules / Instabilité du génome / Mutation / Antinéoplasiques Type d'étude: Prognostic_studies Limites: Animals / Female / Humans Langue: En Journal: Cells Année: 2020 Type de document: Article Pays d'affiliation: Canada Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google